|
PharmaVOICE Podcasts|Regulatory Concerns in Named Patient Programs Episode
Date: 2/19/2008Length: 00:15:01Size: 6.87MB Thought Leader: Maria Kempshall, Head of Regulatory Affairs and Quality Assurance, IDISThis is the second of three IDIS sponsored Podcasts covering named patient programs. In this episode, Ms. Kempshall gives a brief overview on the topic and then provides a detailed discussion on key regulatory issues, factors impacting pharmacovigilance, and finally, how to communicate the availability of a named patient program. Play Full Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
[ Wed, 27 Feb 2008 21:28:00 +0000 ]
|
